StockData
CNBX Pharmaceuticals Inc. logo

CNBX Pharmaceuticals Inc. (CNBX) stock

CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jun 24, 2026Score 0/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $197.79KP/E –Yield –

CNBX Pharmaceuticals statistics

25 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
May 31, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (QoQ)
31.1%
0.50%
Float
1.61B
49M
Shares Held by Insiders
0.00%
11.7%

Returns on capitalIndustry

Return on Assets (ROA)
-2942.3%
-40.6%

Financial positionIndustry

Current Ratio
0.00
3.30
Quick Ratio
0.00
2.39

EfficiencyIndustry

Asset Turnover
0.00
0.40
Revenue Per Employee
$0
$429.29K
Profits Per Employee
-$9
-$689.41K
Employee Count
53,010
74

Income statement (TTM)Industry

Revenue
$0
$66.37M
Operating Income
-$429.46K
-$21.37M
Net Income
-$462.09K
-$22.35M
EBITDA
-$429.46K
-$17.21M

Balance sheetIndustry

Total Debt
$120.00K
$116.91M
Net Cash (Debt)
-$110.51K
$17.76M
Net Cash Per Share
-$0.00
$0.80
Equity (Book Value)
-$2.66M
$53.89M
Book Value Per Share
-$0.00
$1.50
Tangible Book Value
-$2.66M
$27.13M
Working Capital
-$2.66M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$154.17K
-$12.38M

Scores and fair valueIndustry

Piotroski F-Score
2
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodCNBXS&P 500DifferenceCNBX per yearS&P 500 per year
1 month+42.9%+0.6%+42.2 pts
3 months+50.0%+3.4%+46.6 pts
Year to date-62.5%+13.3%−75.8 pts
1 year-70.0%+16.6%−86.6 pts
3 years-99.0%+86.4%−185.4 pts-78.7%+23.1%
5 years-100.0%+81.9%−181.9 pts-90.2%+12.7%
10 years-100.0%+318.9%−418.9 pts-69.1%+15.4%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M CNBX shares were sold short on Oct 30, 2026, up 16000000.0% from the previous report. At recent volumes it would take 1.0 days to buy them back.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026160,001+16000000.0%31,920,9481.0
Oct 15, 20261-100.0%14,103,2691.0
Sep 30, 202669,971-30.0%7,170,5731.0
Sep 15, 2026100,001-87.3%10,440,0311.0
Aug 31, 2026788,894-39.0%4,573,5411.0
Aug 14, 20261,293,928-10.4%1,797,7431.0
Jul 31, 20261,444,389+144438800.0%10,945,9361.0
Jul 15, 20261-100.0%92,742,6311.0
Jun 30, 2026283,205-0.0%60,240,7791.0
Jun 15, 2026283,214-3.4%7,564,5151.0
May 29, 2026293,249-88.5%39,007,3751.0
May 15, 20262,549,897+70145.1%57,447,4411.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?